Dermatologische Nebenwirkungen der Zytostatika

Literatur
1 Chon SY, Champion RW, Geddes ER et al. Chemotherapy-induced alopecia. J Am Acad Dermatol 2012; 67: e37-47
2 Cotsarelis G, Millar SE. Towards a molecular understanding of hair loss and its treatment. Trends Mol Med 2001; 7: 293-301
3 Alley E, Green R, Schuchter L. Cutaneous toxicities of cancer therapy. Curr Opin Oncol 2002; 14: 212-216
4 Forsberg SA. Scalp cooling therapy and cytotoxic treatment. Lancet 2001; 357: 1134
5 Hartmann JT, Ugurel S, Ulrich J et al. Hauttoxizität. Online: http://www.krebsgesellschaft.de/download/ll_o_08.pdf Stand: 23.04.2014
6 Wyatt AJ, Leonard GD, Sachs DL. Cutaneous reactions to chemotherapy and their management. Am J Clin Dermatol 2006; 7: 45-63
7 Arkenau H-T. Therapiemanagement: Capecitabin und das Hand-Fuß-Syndrom. Online: http://www.journalonko.de/aktuellview.php?id=1244 Stand: 23.04.2014
8 Scotté F, Tourani JM, Banu E et al. Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand. J Clin Oncol 2005; 23: 4424-4429
9 Robert C, Soria JC, Spatz A et al. Cutaneous side-effects of kinase inhibitors and blocking antibodies. Lancet Oncol 2005; 6: 491-500
10 Busam KJ, Capodieci P, Motzer R et al. Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225. Br J Dermatol 2001; 144: 1169-1176
11 Gutzmer R, Becker JC, Enk A et al. Management of cutaneous side effects of EGFR inhibitors: recommendations from a German expert panel for the primary treating physician. J Dtsch Dermatol Ges 2011; 9: 195-203
12 Braun-Falco M, Holtmann C, Lordick F et al. Follicular drug reaction from cetuximab: a common side effect in the treatment of metastatic colon carcinoma. Hautarzt 2006; 57: 701-704
13 Tsimboukis S, Merikas I, Karapanagiotou EM et al. Erlotinib-induced skin rash in patients with non-small-cell lung cancer: pathogenesis, clinical significance, and management. Clin Lung Cancer 2009; 10: 106-111